查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1698135

膈肌起搏治疗系统市场－全球产业规模、份额、趋势、机会和预测（按产品、应用、地区和竞争细分，2020-2030 年）

Diaphragm Pacing Therapy System Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By Region & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球横膈膜起搏治疗系统市场价值为 77.1 亿美元，预计在预测期内将实现令人印象深刻的成长，到 2030 年的复合年增长率为 4.06%。近年来，全球膈肌起搏治疗系统市场稳步增长，推动因素包括呼吸系统疾病患病率上升、医疗设备技术进步以及人们对膈肌起搏作为某些患者群体替代疗法的认识不断提高。例如，在欧洲，呼吸系统疾病是欧洲环境署成员国第三大死因。每年有近 42 万人死于呼吸系统疾病，其中 60% 以上与慢性呼吸道疾病 (CRD) 有关（Eurostat，2024a；WHO，2024；IHME，2024）。虽然某些国家因呼吸系统疾病导致的死亡率和疾病负担较高，但尚未发现一致的区域模式。

市场概览
预测期 2026-2030
2024年市场规模 77.1亿美元
2030年市场规模 97.1亿美元
2025-2030 年复合年增长率 4.06%
成长最快的领域 脊髓损伤
最大的市场 北美洲

关键市场驱动因素

呼吸系统疾病盛行率上升

主要市场挑战

初始成本高

主要市场趋势

增强型设备技术

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球横膈膜起搏治疗系统市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 副产品（体外横膈膜起搏器、横膈膜起搏器）
    • 依应用（脊髓损伤、肌萎缩侧索硬化症、其他）
    • 按地区
    • 按公司分类（2024）
  • 产品市场图
    • 按产品
    • 按应用
    • 按地区

第六章：北美横膈膜起搏治疗系统市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美：国家分析
    • 加拿大
    • 墨西哥

第七章：欧洲横膈膜起搏治疗系统市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲：国家分析
    • 英国
    • 法国
    • 义大利
    • 西班牙

第八章：亚太横膈肌起搏治疗系统市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区：国家分析
    • 日本
    • 印度
    • 澳洲
    • 韩国

第九章：南美横膈膜起搏治疗系统市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲：国家分析
    • 阿根廷
    • 哥伦比亚

第 10 章：中东与非洲横膈膜起搏治疗系统市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA：国家分析
    • 沙乌地阿拉伯
    • 阿联酋
    • 科威特

第 11 章：市场动态

  • 驱动程式
  • 挑战

第 12 章：市场趋势与发展

  • 近期发展
  • 併购
  • 产品发布

第 13 章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 顾客的力量
  • 替代产品的威胁

第 14 章：竞争格局

  • LUNGPACER MEDICAL INC.
  • Avery Biomedical Devices, Inc.
  • Synapse Biomedical Inc
  • Astrotech Corp
  • AstraZeneca PLC
  • Novartis AG
  • Boehringer Ingelheim
  • Respironics Ltd
  • Johnson & Johnson (Actelion)
  • PneumRx, LLC

第 15 章：策略建议

第16章调查会社について・免责事项

简介目录
Product Code: 20597

Global Diaphragm Pacing Therapy System Market was valued at USD 7.71 billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 4.06% through 2030. The Global Diaphragm Pacing Therapy System Market has witnessed steady growth in recent years, driven by factors such as the rising prevalence of respiratory disorders, technological advancements in medical devices, and increasing awareness about diaphragm pacing as an alternative therapy for certain patient populations. For instance, in Europe, respiratory disorders rank as the third leading cause of death in European Environment Agency member countries. Annually, nearly 420,000 deaths are attributed to respiratory diseases, with over 60% linked to Chronic Respiratory Diseases (CRDs) (Eurostat, 2024a; WHO, 2024; IHME, 2024). While certain countries experience higher mortality and disease burden from respiratory conditions, no consistent regional pattern has been identified.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 7.71 Billion
Market Size 2030USD 9.71 Billion
CAGR 2025-20304.06%
Fastest Growing SegmentSpinal Cord Injury
Largest MarketNorth America

Key Market Drivers

Rising Prevalence of Respiratory Disorders

The global healthcare landscape is witnessing a significant shift, with a concerning increase in the prevalence of respiratory disorders. These conditions can significantly impair an individual's ability to breathe, leading to a reduced quality of life and, in severe cases, life-threatening situations. However, amidst these challenges, there is a glimmer of hope for patients in the form of diaphragm pacing therapy systems. As the prevalence of respiratory disorders continues to rise, the diaphragm pacing therapy system market is poised for substantial growth. According to WHO, chronic obstructive pulmonary disease (COPD) claims over 3 million lives annually, silently impacting more than 380 million people worldwide. As the fourth leading cause of death globally, COPD has remained underrepresented in global health discussions, despite its profound effects on patients and families. It's time to bring this noncommunicable disease to the forefront and address its devastating impact.

Key Market Challenges

High Initial Costs

One of the most prominent challenges in the diaphragm pacing therapy system market is the high initial costs associated with these devices. The sophisticated technology and intricate surgical procedures required for implantation can result in substantial expenses for both healthcare facilities and patients. The cost may act as a deterrent, limiting access to those who may benefit from diaphragm pacing therapy.

Key Market Trends

Enhanced Device Technology

One of the most prominent trends in the diaphragm pacing therapy system market is the ongoing enhancement of device technology. Manufacturers are investing in research and development to create more advanced, efficient, and patient-friendly systems. This includes devices with improved battery life, wireless connectivity for remote monitoring, and more compact designs for enhanced comfort.

Key Market Players

  • LUNGPACER MEDICAL INC.
  • Avery Biomedical Devices, Inc.
  • Synapse Biomedical Inc
  • Astrotech Corp.
  • AstraZeneca PLC
  • Novartis AG
  • Boehringer Ingelheim
  • Respironics Ltd
  • Johnson & Johnson (Actelion)
  • PneumRx, LLC

Report Scope:

In this report, the Global Diaphragm Pacing Therapy System Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Diaphragm Pacing Therapy System Market, By Product:

  • External Diaphragm Pacemaker
  • Diaphragm Pacemaker

Diaphragm Pacing Therapy System Market, By Application:

  • Spinal Cord Injury
  • Amyotrophic Lateral Sclerosis
  • Others

Diaphragm Pacing Therapy System Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Diaphragm Pacing Therapy System Market.

Available Customizations:

Global Diaphragm Pacing Therapy System market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Diaphragm Pacing Therapy System Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (External Diaphragm Pacemaker, Diaphragm Pacemaker)
    • 5.2.2. By Application (Spinal Cord Injury, Amyotrophic Lateral Sclerosis, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Product Market Map
    • 5.3.1. By Product
    • 5.3.2. By Application
    • 5.3.3. By Region

6. North America Diaphragm Pacing Therapy System Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (External Diaphragm Pacemaker, Diaphragm Pacemaker)
    • 6.2.2. By Application (Spinal Cord Injury, Amyotrophic Lateral Sclerosis, Others)
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Diaphragm Pacing Therapy System Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Diaphragm Pacing Therapy System Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Diaphragm Pacing Therapy System Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application

7. Europe Diaphragm Pacing Therapy System Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product (External Diaphragm Pacemaker, Diaphragm Pacemaker)
    • 7.2.2. By Application (Spinal Cord Injury, Amyotrophic Lateral Sclerosis, Others)
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Diaphragm Pacing Therapy System Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
    • 7.3.2. United Kingdom Diaphragm Pacing Therapy System Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
    • 7.3.3. France Diaphragm Pacing Therapy System Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Diaphragm Pacing Therapy System Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Diaphragm Pacing Therapy System Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application

8. Asia-Pacific Diaphragm Pacing Therapy System Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product (External Diaphragm Pacemaker, Diaphragm Pacemaker)
    • 8.2.2. By Application (Spinal Cord Injury, Amyotrophic Lateral Sclerosis, Others)
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Diaphragm Pacing Therapy System Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
    • 8.3.2. Japan Diaphragm Pacing Therapy System Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
    • 8.3.3. India Diaphragm Pacing Therapy System Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
    • 8.3.4. Australia Diaphragm Pacing Therapy System Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
    • 8.3.5. South Korea Diaphragm Pacing Therapy System Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application

9. South America Diaphragm Pacing Therapy System Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product (External Diaphragm Pacemaker, Diaphragm Pacemaker)
    • 9.2.2. By Application (Spinal Cord Injury, Amyotrophic Lateral Sclerosis, Others)
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Diaphragm Pacing Therapy System Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
    • 9.3.2. Argentina Diaphragm Pacing Therapy System Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
    • 9.3.3. Colombia Diaphragm Pacing Therapy System Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application

10. Middle East and Africa Diaphragm Pacing Therapy System Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product (External Diaphragm Pacemaker, Diaphragm Pacemaker)
    • 10.2.2. By Application (Spinal Cord Injury, Amyotrophic Lateral Sclerosis, Others)
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Diaphragm Pacing Therapy System Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
    • 10.3.2. Saudi Arabia Diaphragm Pacing Therapy System Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
    • 10.3.3. UAE Diaphragm Pacing Therapy System Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application
    • 10.3.4. Kuwait Diaphragm Pacing Therapy System Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Product
        • 10.3.4.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. LUNGPACER MEDICAL INC.
  • 14.2. Avery Biomedical Devices, Inc.
  • 14.3. Synapse Biomedical Inc
  • 14.4. Astrotech Corp
  • 14.5. AstraZeneca PLC
  • 14.6. Novartis AG
  • 14.7. Boehringer Ingelheim
  • 14.8. Respironics Ltd
  • 14.9. Johnson & Johnson (Actelion)
  • 14.10. PneumRx, LLC

15. Strategic Recommendations

16. About Us & Disclaimer